Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Genzyme Corp (GENZ)
since 2010 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Genzyme Corp.
Table 2 shows the detailed insider transactions.
This company's CIK number is 732485.
Total stock buying since 2010: $789,301,318.
Total stock sales since 2010: $19,468,346.
Total stock option exercises since 2010: $8,855,381.
Table 3. Detailed insider trading at Genzyme Corp (GENZ)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2011-04-08 | Gc Merger Corp. (10% Owner) | Buy | 20,681,287 | 38.16 | 789,301,318 |
| 2011-04-07 | Gc Merger Corp. (10% Owner) | Buy | 44,891,208 | .00 | 0 |
| 2011-04-06 | Gc Merger Corp. (10% Owner) | Buy | 3,947,680 | .00 | 0 |
| 2011-04-04 | Ende Eric J (Director) | Option Ex | 2,375 | .00 | 0 |
| 2011-04-04 | Burakoff Steven (Director) | Option Ex | 2,375 | .00 | 0 |
| 2011-04-04 | Amello Jason (CorpContrllr,ChiefAccntOfficer) | Option Ex | 5,005 | .00 | 0 |
| 2011-04-04 | Desrosier Thomas (Sr VP, General Counsel) | Option Ex | 11,375 | .00 | 0 |
| 2011-04-04 | Meeker David P (ExecVP,Chief Operating Officer) | Option Ex | 29,250 | .00 | 0 |
| 2011-04-04 | Canute Scott A (Executive VP) | Option Ex | 25,000 | .00 | 0 |
| 2011-04-04 | Boudreaux Gail (Director) | Option Ex | 2,375 | .00 | 0 |
| 2011-04-04 | Bertolini Robert J (Director) | Option Ex | 2,375 | .00 | 0 |
| 2011-04-04 | Smith Sandford D (Exe VP,President Int'l Group) | Option Ex | 14,500 | .00 | 0 |
| 2011-04-04 | Geraghty James A (Senior Vice President) | Option Ex | 9,750 | .00 | 0 |
| 2011-04-04 | Wyzga Michael S (Executive VP and CFO) | Option Ex | 29,250 | .00 | 0 |
| 2011-04-04 | Csimma Zoltan A (SrVP,Chief Human Resources Officer) | Option Ex | 5,640 | .00 | 0 |
| 2011-04-04 | Dzau Victor J (Director) | Option Ex | 6,318 | .00 | 0 |
| 2011-04-04 | Syron Richard F/ca (Director) | Option Ex | 2,375 | .00 | 0 |
| 2011-04-04 | Fenton Dennis M (Director) | Option Ex | 2,375 | .00 | 0 |
| 2011-04-04 | Mcgillicudy Cornelius Iii (Director) | Option Ex | 8,280 | .00 | 0 |
| 2011-04-04 | Berthiaume Douglas A (Director) | Option Ex | 11,380 | .00 | 0 |
| 2011-04-04 | Whitworth Ralph V (Director) | Option Ex | 2,375 | .00 | 0 |
| 2011-04-04 | Cooney Charles L (Director) | Option Ex | 6,352 | .00 | 0 |
| 2011-04-04 | Carpenter Robert J (Director) | Option Ex | 2,375 | .00 | 0 |
| 2011-04-04 | Wirth Peter (Exec VP,Legal & Corporate Dev.) | Option Ex | 29,250 | .00 | 0 |
| 2011-04-04 | Termeer Henri A (Chmn, President and CEO) | Option Ex | 64,768 | .00 | 0 |
| 2011-04-04 | Smith Alan E (Sr VP,Chief Scientific Officer) | Option Ex | 7,815 | .00 | 0 |
| 2011-04-04 | Moscicki Richard A (Sr VP,Chief Medical Officer) | Option Ex | 15,762 | .00 | 0 |
| 2010-08-31 | Amello Jason (Corp Contrllr,ChiefAccntOfficr) | Sale | 6,640 | 70.30 | 466,792 |
| 2010-08-31 | Amello Jason (Corp Contrllr,ChiefAccntOfficr) | Option Ex | 6,640 | 46.24 | 307,033 |
| 2010-07-23 | Smith Sandford D (Exe VP,President Int'l Group) | Sale | 32,041 | 64.53 | 2,067,701 |
| 2010-07-23 | Smith Sandford D (Exe VP,President Int'l Group) | Option Ex | 32,041 | 43.88 | 1,405,959 |
| 2010-07-12 | Csimma Zoltan A (SrVP,Chief Human Resources Officer) | Sale | 63,746 | 53.82 | 3,430,809 |
| 2010-07-12 | Csimma Zoltan A (SrVP,Chief Human Resources Officer) | Option Ex | 63,746 | 35.96 | 2,292,306 |
| 2010-06-16 | Boudreaux Gail (Director) | Option Ex | 2,500 | .00 | 0 |
| 2010-06-16 | Bertolini Robert J (Director) | Option Ex | 2,375 | .00 | 0 |
| 2010-06-16 | Dzau Victor J (Director) | Option Ex | 2,500 | .00 | 0 |
| 2010-06-16 | Syron Richard F/ca (Director) | Option Ex | 2,500 | .00 | 0 |
| 2010-06-16 | Mcgillicudy Cornelius Iii (Director) | Option Ex | 2,500 | .00 | 0 |
| 2010-06-16 | Berthiaume Douglas A (Director) | Option Ex | 2,500 | .00 | 0 |
| 2010-06-16 | Whitworth Ralph V (Director) | Option Ex | 2,375 | .00 | 0 |
| 2010-06-16 | Cooney Charles L (Director) | Option Ex | 2,500 | .00 | 0 |
| 2010-06-16 | Carpenter Robert J (Director) | Option Ex | 2,500 | .00 | 0 |
| 2010-06-11 | Geraghty James A (Senior Vice President) | Sale | 1,000 | 48.81 | 48,810 |
| 2010-05-27 | Smith Alan E (Sr VP,Chief Scientific Officer) | Sale | 1,737 | 49.54 | 86,050 |
| 2010-05-25 | Amello Jason (CorpContrllr,ChiefAccntOfficer) | Sale | 533 | 45.62 | 24,315 |
| 2010-05-25 | Desrosier Thomas (Sr VP, General Counsel) | Sale | 1,972 | 45.60 | 89,923 |
| 2010-05-25 | Meeker David P (ExecVP,Chief Operating Officer) | Sale | 2,732 | 45.60 | 124,579 |
| 2010-05-25 | Smith Sandford D (Exe VP,President Int'l Group) | Sale | 8,887 | 45.61 | 405,336 |
| 2010-05-25 | Geraghty James A (Senior Vice President) | Sale | 2,329 | 45.59 | 106,179 |
| 2010-05-25 | Wyzga Michael S (Executive VP and CFO) | Sale | 5,068 | 45.63 | 231,252 |
| 2010-05-25 | Csimma Zoltan A (SrVP,Chief Human Resources Officer) | Sale | 2,629 | 45.61 | 119,908 |
| 2010-05-25 | Wirth Peter (Exec VP,Legal & Corporate Dev.) | Sale | 6,665 | 45.62 | 304,057 |
| 2010-05-25 | Termeer Henri A (Chmn, President and CEO) | Sale | 39,695 | 45.61 | 1,810,488 |
| 2010-05-25 | Smith Alan E (Sr VP,Chief Scientific Officer) | Sale | 4,789 | 45.62 | 218,498 |
| 2010-05-25 | Moscicki Richard A (Sr VP,Chief Medical Officer) | Sale | 2,731 | 45.63 | 124,615 |
| 2010-05-24 | Amello Jason (CorpContrllr,ChiefAccntOfficer) | Option Ex | 1,575 | .00 | 0 |
| 2010-05-24 | Desrosier Thomas (Sr VP, General Counsel) | Option Ex | 5,833 | .00 | 0 |
| 2010-05-24 | Meeker David P (ExecVP,Chief Operating Officer) | Option Ex | 8,083 | .00 | 0 |
| 2010-05-24 | Smith Sandford D (Exe VP,President Int'l Group) | Sale | 1,525 | 48.93 | 74,618 |
| 2010-05-24 | Smith Sandford D (Exe VP,President Int'l Group) | Option Ex | 15,000 | .00 | 0 |
| 2010-05-24 | Geraghty James A (Senior Vice President) | Option Ex | 5,000 | .00 | 0 |
| 2010-05-24 | Wyzga Michael S (Executive VP and CFO) | Option Ex | 15,000 | .00 | 0 |
| 2010-05-24 | Csimma Zoltan A (SrVP,Chief Human Resources Officer) | Sale | 593 | 48.93 | 29,015 |
| 2010-05-24 | Csimma Zoltan A (SrVP,Chief Human Resources Officer) | Option Ex | 5,833 | .00 | 0 |
| 2010-05-24 | Wirth Peter (Exec VP,Legal & Corporate Dev.) | Option Ex | 15,000 | .00 | 0 |
| 2010-05-24 | Termeer Henri A (Chmn,President and CEO) | Sale | 8,955 | 48.93 | 438,168 |
| 2010-05-24 | Termeer Henri A (Chmn, President and CEO) | Option Ex | 67,000 | .00 | 0 |
| 2010-05-24 | Smith Alan E (Sr VP,Chief Scientific Officer) | Option Ex | 8,083 | .00 | 0 |
| 2010-05-24 | Moscicki Richard A (Sr VP,Chief Medical Officer) | Option Ex | 8,083 | .00 | 0 |
| 2010-05-22 | Smith Sandford D (Exe VP,President Int'l Group) | Option Ex | 5,000 | .00 | 0 |
| 2010-05-22 | Csimma Zoltan A (SrVP,Chief Human Resources Officer) | Option Ex | 1,944 | .00 | 0 |
| 2010-05-22 | Termeer Henri A (Chmn, President and CEO) | Option Ex | 22,333 | .00 | 0 |
| 2010-05-22 | Smith Alan E (Sr VP,Chief Scientific Officer) | Option Ex | 2,694 | .00 | 0 |
| 2010-05-21 | Meeker David P (ExecVP,Chief Operating Officer) | Sale | 16,488 | 49.06 | 808,901 |
| 2010-05-21 | Meeker David P (ExecVP,Chief Operating Officer) | Option Ex | 16,488 | 26.50 | 436,932 |
| 2010-05-21 | Smith Sandford D (Exe VP,President Int'l Group) | Option Ex | 4,750 | .00 | 0 |
| 2010-05-21 | Csimma Zoltan A (SrVP,Chief Human Resources Officer) | Option Ex | 1,847 | .00 | 0 |
| 2010-05-21 | Termeer Henri A (Chmn,President and CEO) | Option Ex | 21,216 | .00 | 0 |
| 2010-05-21 | Smith Alan E (Sr VP,Chief Scientific Officer) | Sale | 822 | 48.93 | 40,220 |
| 2010-05-21 | Smith Alan E (Sr VP,Chief Scientific Officer) | Option Ex | 2,559 | .00 | 0 |
| 2010-05-17 | Wirth Peter (Exec VP,Legal & Corporate Dev.) | Sale | 48,216 | 50.51 | 2,435,390 |
| 2010-05-17 | Wirth Peter (Exec VP,Legal & Corporate Dev.) | Option Ex | 48,216 | 26.50 | 1,277,724 |
| 2010-05-17 | Termeer Henri A (Chmn, President and CEO) | Sale | 100,000 | 50.54 | 5,054,000 |
| 2010-05-17 | Termeer Henri A (Chmn, President and CEO) | Option Ex | 100,000 | 26.50 | 2,650,000 |
| 2010-05-14 | Moscicki Richard A (Sr VP,Chief Medical Officer) | Sale | 18,318 | 50.70 | 928,722 |
| 2010-05-14 | Moscicki Richard A (Sr VP,Chief Medical Officer) | Option Ex | 18,318 | 26.50 | 485,427 |
Insider trading activities including stock purchases, stock sales, and option exercises
of GENZ listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Genzyme Corp (symbol GENZ,
CIK number 732485) see
the Securities and Exchange Commission (SEC) website.